Who Owns EPRX?

Eupraxia Pharmaceuticals Inc. — Institutional Ownership & 13F Holdings

$7.20

+0.04 (+0.56%)

Market Cap

$261.8M

Shares Outstanding

33,480,000

Institutional Holders

11

Total Inst. Value

$7.1M

% of Float Held

QoQ Holder Change

Institutional data as of Q1 2025

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1SCOTIA CAPITAL INC.$5.1M1,552,679
2ROYAL BANK OF CANADA$1.1M342,828
3TD Waterhouse Canada Inc.$343K104,986
4BANK OF MONTREAL /CAN/$171K52,250
5UBS Group AG$168K51,199
6GOLDMAN SACHS GROUP INC$113K34,500
7CITADEL ADVISORS LLC$39K12,054
8RAYMOND JAMES FINANCIAL INC$37K11,133
9JPMORGAN CHASE & CO$8K2,700
10BANK OF AMERICA CORP /DE/$7K2,500

Biggest Buyers & Sellers This Quarter

Top Buyers

FundShares AddedValue
SCOTIA CAPITAL INC.+161K$5.1M
ROYAL BANK OF CANADA+60K$1.1M
UBS Group AG+23K$168K
NATIONAL BANK OF CANADA /FI/+721$2K

Top Sellers

FundShares RemovedValue
BANK OF MONTREAL /CAN/-5K$171K
RAYMOND JAMES FINANCIAL INC-480$37K

Related Stocks

Frequently Asked Questions

How many institutional investors hold EPRX?

As of Q1 2025, 11 institutional investors report holding EPRX (Eupraxia Pharmaceuticals Inc.) in their 13F filings.

Which hedge fund owns the most EPRX?

The largest institutional holder of EPRX is SCOTIA CAPITAL INC. with $5.1M in shares.

Are institutions buying or selling EPRX?

This quarter, 4 institutions opened new positions in EPRX and 3 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.